PRESTIGE CONSUMER HEALTHCARE PBH
ASignal's systematic analysis rates PBH as Neutral.
Reflects the latest available analysis · analyzed Sep 25, 2026
The case on PBH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin (54.77%) indicating pricing power
- Attractive valuation metrics: forward P/E of 8.98x and PEG of 1.45x
- Positive free cash flow of $147.89M
- Low debt-to-equity ratio of 1.08x with manageable leverage
- Current ratio of 3.23x suggests solid short-term financial health
- RSI of 21.37 indicates oversold conditions, potential for reversal
- Negative price momentum (-3.57%) and trading below key moving averages
- MACD below signal line with negative histogram, indicating bearish trend
- Earnings growth declining YoY by 35.80%
- Limited Reddit and news volume suggesting low retail and institutional interest
See the full verdict on PBH
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PBH
Most investors never get a second opinion, let alone several. ASignal runs PBH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.